Skip to Main Content

Paper Details

Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma.
Eur J Cancer
19
2022
Lu-DOTATATE, ONB, Olfactory neuroblastoma, SSTR2, cancer of the sinonasal region, olfactory neuroblastoma, patients, somatostatin, somatostatin receptor 2
Author NameAffiliation
Johannes HaybaeckInstitute of Pathology, Medical University of Innsbruck, Austria Diagnostic & Research Center for Molecular BioMedicine, Medical University Graz
Thomas S JacquesUCL Great Ormond Street Institute of Child Health, Great Ormond Street Hospital for Children NHS Foundation Trust
Wendell G YarbroughUNC School of Medicine
Wendell G YarbroughUNC School of Medicine
David CapperCharite - Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin, German Cancer Research Center (DKFZ)
David CapperCharite - Universitatsmedizin Berlin, Corporate Member of Freie Universitat Berlin and Humboldt-Universitat zu Berlin, German Cancer Research Center (DKFZ)
Ulrich Sch??llerInstitute of Neuropathology, And Research Institute Children's Cancer Center, University Medical Center Hamburg-Eppendorf
Zara M PatelStanford University School of Medicine
Jayakar V NayakStanford University School of Medicine
Peter H HwangStanford University School of Medicine
Gary L GalliaJohns Hopkins School of Medicine, Johns Hopkins University School of Medicine
  • 1 - 11

Datasets